You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
威高骨科(688161.SH):目前脊柱、創傷、關節三大領域全部集採並落地執行,產品終端價格的下降對公司經營業績有一定的影響
格隆匯 06-08 11:13

格隆匯6月8日丨有投資者向威高骨科(688161.SH)提問,“請問公司一季報公佈以後,股價連續陰跌,是市場對公司業績的不認可?還是對集採後業績的擔憂?又或者是資金對公司併購子公司新生醫療的不認可?”

威高骨科回覆稱,目前脊柱、創傷、關節三大領域全部集採並落地執行,產品終端價格的下降對公司經營業績有一定的影響。公司會利用集採環境下行業集中度提升的機會,充分發揮國產龍頭企業全產業、多品牌的優勢,不斷提高手術量,擴大市場份額。公司併購新生公司是公司拓寬業務佈局、提高可持續發展能力的重要舉措,有利於進一步提升公司的盈利能力。根據股權收購協議,2023年新生業績承諾扣非後淨利潤6720萬元,新生業績承諾期內年度扣非淨利潤增長不低於20%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account